Martin & Co. Inc. TN lowered its position in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 5.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 499,151 shares of the company's stock after selling 29,204 shares during the quarter. TruBridge comprises 2.4% of Martin & Co. Inc. TN's holdings, making the stock its 6th biggest position. Martin & Co. Inc. TN owned 3.34% of TruBridge worth $9,843,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the business. Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of TruBridge during the 3rd quarter worth approximately $5,934,000. CacheTech Inc. acquired a new stake in TruBridge in the third quarter worth $2,875,000. Invenomic Capital Management LP bought a new stake in TruBridge in the third quarter valued at $2,364,000. Geode Capital Management LLC acquired a new position in shares of TruBridge during the third quarter valued at about $1,747,000. Finally, Rice Hall James & Associates LLC acquired a new stake in shares of TruBridge in the 3rd quarter valued at about $1,143,000. 88.64% of the stock is currently owned by institutional investors and hedge funds.
In related news, Director Mark V. Anquillare bought 2,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were acquired at an average cost of $16.81 per share, with a total value of $42,025.00. Following the completion of the purchase, the director now directly owns 17,178 shares of the company's stock, valued at $288,762.18. This trade represents a 17.03 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 3.60% of the company's stock.
A number of brokerages have commented on TBRG. Stephens boosted their price target on shares of TruBridge from $13.00 to $17.00 and gave the company an "equal weight" rating in a research note on Wednesday, November 20th. Barclays raised their price objective on shares of TruBridge from $10.00 to $14.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th.
Check Out Our Latest Analysis on TBRG
TBRG stock opened at $28.17 on Monday. The firm has a 50 day moving average of $21.84 and a 200-day moving average of $16.31. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80. TruBridge, Inc. has a 12 month low of $7.55 and a 12 month high of $28.58.
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.